Tetrahedron Letters
Total synthesis of (R)-tylophorine by using an asymmetric
hydrogenation of the allyl alcohol
⇑
⇑
Rui Li , Chun-Fang Liu, Chun-Jiao Yu, Peiming Gu
College of Chemistry & Chemical Engineering, Ningxia Engineering and Research Center for Natural Medicines, Ningxia University, Yinchuan 750021, China
a r t i c l e i n f o
a b s t r a c t
Article history:
An efficient synthesis of naturally occurring (R)-tylophorine is described. The alkaloid was prepared in
seven steps from a known phenanthryl aldehyde with an overall yield of 14.2%. Asymmetric hydrogena-
tion of an allyl alcohol was employed as a key step for installing a stereogenic center with good enantios-
Received 8 March 2018
Revised 17 April 2018
Accepted 21 April 2018
Available online 24 April 2018
electivity (77% ee), and the ee value of the
x
-chloro alcohol was improved to 95% by recrystallization.
-chloro alcohol to the precursor of the Schmidt
After azidation and oxidation of the enantio-enriched
x
reaction, the chirality transfer in the stereospecific 1,2-migration furnished the chiral carbon in the
alkaloid. Finally, a one-pot deformylation/Pictet-Spengler cyclization completed the total synthesis of
(R)-tylophorine.
Keywords:
Tylophorine
Total synthesis
Asymmetric hydrogenation
Schmidt reaction
Ó 2018 Elsevier Ltd. All rights reserved.
OMe
Tylophorine 1 (Fig. 1), a phenanthroindolizidine alkaloid featur-
ing with a pentacyclic motif, was initially isolated from Tylophora
indica plant family.1 It exhibits remarkable antitumor,2 antiinflam-
matory,3 and antifungal activities,4 therefore many groups had
reported their synthesis of the racemate tylophorine,5 naturally
occurring (R)-tylophorine,6,7 and its antipode (S)-tylophorine.8,9
Most of the synthetic methods toward the optically active tylo-
phorine were based on the chiral materials or auxiliaries,6,8 and
only four different synthetic routes had been developed for con-
structing the stereogenic center of tylophorine via the catalytic
asymmetric reactions. The Pd-7a and Cu-catalyzed9b asymmetric
alkene carboamination reactions were used by Wolfe’s group and
Chemler’s group, and the corresponding intermediates for
synthesis of the enanito-enriched tylophorine were produced
with good enantioselectivities (88% ee and 81% ee, respectively).
Wang’s group had reported that the asymmetric allylation of an
aldehyde could be used as a key step for synthesis of (S)-
MeO
MeO
H
N
OMe
(R)-tylophorine 1
Fig. 1. Structure of naturally occurring tylophorine.
( )-antofine,10 another attractive phenanthroindolizidine alkaloid
for researchers. An intramolecular Schmidt reaction of the alkyl
azide with an aldehyde was served as a key conversion in our pre-
vious synthesis of ( )-antofine, and the Schmidt rearrangement
had been demonstrated as a stereospecific process, where the
stereochemistry of the migration group could be maintained.11
Therefore, the synthesis of optically active tylophorine could be
conveniently addressed if the enantio-enriched precursor of the
Schmidt reaction could be prepared.
tylophorine, affording
a
homoallylic alcohol with 86% ee.9a
Yamaoka and co-workers had reported the synthesis of (R)-
tylophorine based on an asymmetric transfer hydrogenation of a
cyclic imine for creating the chirality (84% ee).7b In this paper,
we present an enantioselective synthesis of the (R)-tylophorine
by using a catalytic asymmetric hydrogenation for installing the
stereogenic center.
With this in mind, we started the synthesis from the known
phenanthryl aldehyde 212 and
a substituted phosphonate 3
(Scheme 1). The aldehyde could be easily prepared according to
the literature12a through four steps conversion, and the
phosphonate 3 was obtained via the synthetic procedure we
reported.10 The Horner-Wadsworth-Emmons condensation of the
phenanthryl aldehyde 2 with phosphonate 3 was carried out in
Our synthesis of (R)-tylophorine employed the strategy analo-
gous to our previously reported method for preparation of the
⇑
Corresponding authors.
the presence of 2.0 equiv of NaH, affording the a,b-unsaturated ester
0040-4039/Ó 2018 Elsevier Ltd. All rights reserved.